Analysis

The latest Drug Channels commentary — PBMs, 340B, specialty pharmacy, and the contracts that move the money.

Showing 441–450 of 2721

Wednesday, March 29, 2023

Tuesday, March 28, 2023

Monday, March 27, 2023

  • Behind the GoodRx-Express Scripts Partnership: How PBMs Profit from Discount Cards in Pharmacy Benefits (rerun)

    This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Discount Cards, Cost-Plus Pharmacies, and PBMs: Trends, Controversies, and Outlook. Friday's webinar will include my latest thoughts on a key trend discussed in todays rerun: how plan sponsors are incorporating patient-paid prescriptions—cash-pay prescriptions and discount cards—within pharmacy benefits.

    Click here to see the original post and comments from November 2022.


    Last week, GoodRx announced that it would become the exclusive prescription discount card provider for the commercial beneficiaries of Cigna’s Express Scripts. Links below.

    The rise of discount card pricing within pharmacy benefit plans is a positive development. Patients get access to market prices that can be lower than their PBM’s contracted rate. All out-of-pocket spending with a discount card counts toward a patient's deductibles, and all prescription activity gets captured.

    However, I suspect few people understand that placing discount cards within the pharmacy benefit enables a PBM to monetize a new fee stream from the card vendor. Below, I walk through this booming business and highlight some of the conflicts and contradictions underneath the coconuts.

    Posted by Drug Channels Institute, an HMP Global company on Monday, March 27, 2023

    Labels: Generic Drugs, Costs/Reimbursement, Discount Cards, Benefit Design, PBMs, Pharmacy Economics

Friday, March 24, 2023

Tuesday, March 21, 2023

Monday, March 20, 2023

  • Informa Connect’s Annual Life Sciences Commercial Contracts & Chargebacks Congress

    Informa Connect’s Annual Life Sciences Commercial Contracts & Chargebacks Congress
    May 16-17, 2023
    The Omni Shoreham Hotel | Washington, DC
    Hybrid Event
    informaconnect.com/contracts-chargebacks

    Exclusive Offer for Drug Channels Readers: Register Now to SAVE 10%* using promo code 23DC10

    Informa Connect’s 19th Annual Commercial Contracts & Chargebacks Congress, taking place May 16-17 in Washington, DC, offers crucial updates on policy changes and contracting best practices to increase efficiency, reduce revenue leakage, and streamline chargeback excellence. This annual event has become a must-attend for pricing and contracting professionals in the life sciences industry with seasoned leaders and forward-thinking strategies on display. Join industry stakeholders, including manufacturers, wholesalers, GPOs and more, for a robust two-day event offering extended content and actionable strategies in key interest areas in the ever-evolving contracting landscape.

    Featured Faculty Driving the Conversation:
    • Rosalind Davis, Government Pricing & Contracts Director, Vifor Pharma, Inc.
    • Stephani Kupski, Director, U.S. Pricing & Government Reporting, CSL Behring
    • Mallory O’Connor, Public Policy Executive Director, Mallinckrodt
    • Cad Snyder, Director, Global Finance Shared Services, Cardinal Health
    • Beth Stevens, Associate Director, Contracts and Pricing, Tolmar Inc.
    • Roxana Santiago, Director Controlling Revenue Accounting, Fresenius Kabi USA LLC
    • Jennifer Plemmons Crosswell, Director, Contracts & Pricing, Accounting, Azurity Pharmaceuticals
    • Mitesh Ghia, Director, Chargebacks, Membership, Rebates & Contract Administration, Novartis Pharmaceuticals Corporations
    • Elizabeth Johnson, President, National Association of Medication Access & Patient Advoacacy
    • Erika Chiles-George, Pricing & Trade Director, Contracts, Neurocrine Biosciences
    • And many more!
    Hight Impact Topics Transforming the Market Include:
    • Commercial Contract Model Landscape
    • Assessing the Impact of IRA on Product Calculations
    • 340B Drug Discount Program — Ongoing Monitoring of 340B Program Risks & Best Practices
    • Multi-Stakeholder Panel — Membership and Class of Trade
    • Updated Review and Interpretation of the Inflation Reduction Act
    • GTN Forecasting Across Different Channels
    • PLUS! — Customize Your Learning by Choosing Between Two Thought-Provoking Tracks:
      • Contracts and Chargebacks Excellence
      • Analytical and Technology Innovation
    • and more!
    NEW THIS YEAR! The 2023 Summit is Part of Life Sciences Pricing & Contracting USA Uniting three industry leading events — Medicaid & Government Pricing Congress, Drug Pricing Transparency Congress and Life Sciences Commercial Contracts & Chargebacks — Life Sciences Pricing & Contracting USA is the industry’s go-to resource for gaining critical insight on regulatory requirements, policy initiatives and best practices to enhance pricing and contracting models. Attend your preferred event and prepare for critical content tailored to your focus area, plus benefit from a more diverse speaking faculty and greater networking opportunities to expand your network and establish powerful partnerships.

    ENHANCE YOUR EXPERIENCE!


    Attendees of Commercial Contracts & Chargebacks 2023 have the option to add a third day of content to their schedule and join the Medicaid & Government Pricing Congress attendees for their final day. Benefit from a fireside chat, in-depth sessions and learning streams, plus additional networking opportunities!

    Drug Channels readers are eligible for an exclusive savings of 10% off* the standard rate by using promo code 23DC10, so download the complete conference agenda and reserve your seat today!

    *Expires 5/16/2023; applies to current rate only and may not be combined or applied to existing registrations; other restrictions may apply


    The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees. To find out how you can promote an event on Drug Channels, please contact Paula Fein (paula@drugchannels.net).

    Posted by Drug Channels Institute, an HMP Global company on Monday, March 20, 2023

    Labels: Sponsored Post

Friday, March 17, 2023

  • It's Not All Bad News: Data Shows There's a Collaborative Future for 340B

    Today’s guest post comes from Rhiannon Naslund, Chief Marketing Officer at Kalderos.

    Rhiannon discusses the growing collaboration between manufacturers and covered entities regarding 340B discount claims. She goes on to describe the Kalderos Discount Hub solution that reviews claims that have a high likelihood of being a duplicate discount.

    To stay up-to-date with the latest drug discount developments, sign up for the Kalderos newsletter.

    Read on for Rhiannon’s insights.

    Posted by Drug Channels Institute, an HMP Global company on Friday, March 17, 2023

    Labels: Guest Post, Sponsored Post

Tuesday, March 14, 2023

Monday, March 13, 2023

  • Informa Connect’s Medicaid & Government Pricing Congress

    Informa Connect’s Medicaid & Government Pricing Congress
    May 16-18, 2023 in Washington, DC
    www.informaconnect.com/medicaid2023
    Drug Channels readers save 10% with code 23DRCH10*

    Join the life science industry on May 16-18, 2023 in Washington, DC at the Medicaid & Government Pricing Congress to conquer complex Medicaid regulatory guidelines and evolve strategies to contract, report and comply with federal and state healthcare programs.

    View the agenda for Medicaid & GP 2023 to see the complete picture – the program, speakers, and more, and visit www.informaconnect.com/medicaid-government-pricing for further details and to register. Drug Channels readers will save 10% off when they use code 23DRCH10 and register prior to April 7, 2023.*

    When you join Informa Connect in Washington, DC, you'll hear from leading GP experts on the latest MDRP trends and strategies that impact you and your business. Some of the companies leading the dialogue include Ascendis Pharma, AstraZenca, Bayer, Blueprint Medicines, Bristol Myers Squibb, CSL Behring, Department of Health & Human Services, Endo, Genentech, Gilead, Mallinckrodt, Neurocrine Biosciences, Novartis, Pfizer, PhRMA, Sanofi, Takeda, Teva, UCB, United Therapeutics, Viatris and more.

    Here are just a few of the sessions you'll attend:
    • Everything Inflation Reduction Act – Both interpretation and implementation guidance
    • Your Medicaid wish list – 30+ years into the program, what would your recommendations to CMS be?
    • The latest and greatest 340B litigation and operational updates
    • Refresh of the inclusion of territories, and hear from Puerto Rico Medicaid on their processes
    • Panel on market access and pricing strategy considerations for early R&D
    • Join a senior-level work group on policy reform for Medicaid and government pricing programs
    • Discuss the intersection of line extensions and AMP cap in-depth
    • Back by popular demand – Fundamentals of GP, the fireside chat with external counsel, and the state-by-state review of SPTR
    • Topics on class of trade, strategies for product launch, moving your data to the cloud, intro to blockchain for GP professionals, discussion on bots and automation and much more!
    Informa Connect is also thrilled that this year's Congress is part of Pricing & Contracting USA! You'll have the benefit of networking with like-minded executives from across the life science industry as we bring together attendees from three industry leading events (the Medicaid & Government Pricing Congress, the Drug Pricing Transparency Congress and the Commercial Contracts & Chargebacks Summit) in the pricing and contracting arena.

    View the agenda for Medicaid & GP 2023 to see the complete picture – the program, speakers, and more, and visit www.informaconnect.com/medicaid-government-pricing for further details and to register. Drug Channels readers will save 10% off when they use code 23DRCH10 and register prior to April 7, 2023.*

    *Cannot be combined with other offers or used towards a current registration. Cannot be combined with special category rates or other offers. Other restrictions may apply.


    The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees. To find out how you can promote an event on Drug Channels, please contact Paula Fein (paula@drugchannels.net).

    Posted by Drug Channels Institute, an HMP Global company on Monday, March 13, 2023

    Labels: Sponsored Post

Friday, March 10, 2023